Improvement of the Oral Bioavailability of Naltrexone in Dogs: A Prodrug Approach
- 30 April 1987
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 76 (5) , 356-358
- https://doi.org/10.1002/jps.2600760503
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Pharmacokinetics of Morphine and Its Surrogates V:Naltrexone and Naltrexone Conjugate Pharmacokinetics in the Dog as a Function of DoseJournal of Pharmaceutical Sciences, 1985
- METABOLISM OF METHYLDOPA IN MAN AFTER ORAL-ADMINISTRATION OF THE PIVALOYLOXYETHYL ESTER1984
- METABOLISM AND DISPOSITION OF NALTREXONE IN MAN AFTER ORAL AND INTRAVENOUS ADMINISTRATION1981
- EVALUATION OF SUCCINIMIDOETHYL AND PIVALOYLOXYETHYL ESTERS AS PROGENITORS OF METHYLDOPA IN MAN, RHESUS-MONKEY, DOG, AND RAT1978
- Improved delivery through biological membranes. 4. Prodrugs of L-DOPAJournal of Medicinal Chemistry, 1977
- Naltrexone and CyclazocineArchives of General Psychiatry, 1977
- ESTIMATION OF SYSTEMIC AVAILABILITY AND OTHER PHARMACOKINETIC PARAMETERS OF NALTREXONE IN MAN AFTER ACUTE AND CHRONIC ORAL-ADMINISTRATION1977
- The metabolism and clinical activity of terbutaline and its prodrug ibuterolEuropean Journal of Clinical Pharmacology, 1976
- Studies of EN-1639A (Naltrexone): A New Narcotic AntagonistAmerican Journal of Psychiatry, 1974
- A Sustained Release Depot for Narcotic AntagonistsArchives of General Psychiatry, 1974